tirzepatide phase 3 Efficacy of in 2 (GPGB; [14]) and phase (SURPASS-1 Microdosing tirzepatide chart: complete week-by-week

Prog Neuro-Psychopharmacol Biol Psychiatry 44: 154161

You have prediabetes with modest weight goals: If your goal is primarily metabolic improvement (better blood sugar) with incidental modest weight loss, metformin may suffice

Research conducted in animal models has shown that BPC-157 can accelerate the healing of muscles, tendons, ligaments, and even the gut lining

Side effects included nausea (39% of patients), diarrhea (25%) and vomiting (28%) [29] Overall, orfoglipron achieves comparable weight loss with other GLP1R agonists such as semaglutide and Rybelsus, but has a slightly better side effect profile and achieves weight loss in a shorter period of time